CSIR lab develops potential clot buster drug for stroke, licences it for clinical trials - Livemint
Livemint
×
HomeBudget 2019 Companies Money Industry Technology Politics Opinion LoungeMultimediaAI Science Education Sports ConsumerSpecials
×